Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET-CT and FEA for AAA Rupture Risk
NCT03231397Phase 4Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Aug 2017
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of [11C]PBR-28, fludeoxyglucose f 18 in abdominal aortic aneurysm (AAA), sponsored by Washington University School of Medicine. Started Aug 2017; status: terminated.
02
Drugs
[11C]PBR-28fludeoxyglucose f 18
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on NCT03231397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03231397.